Stress Urinary Incontinence (SUI)DYNA-SUINCT07075900
Dynamic Neuromuscular Stabilization vs Pelvic Floor Muscle Training in Women With Stress Urinary Incontinence
A study testing Dynamic Neuromuscular Stabilization Training and Pelvic Floor Muscle Training in people with Stress Urinary Incontinence (SUI) and Dynamic Neuromuscular Stabilization, run by Izmir Katip Celebi University at 1 site in Turkey (Türkiye).
Trial summary
This randomized controlled trial aims to compare the pre- and post-treatment effects of Dynamic Neuromuscular Stabilization (DNS) training and Pelvic Floor Muscle Training (PFMT) on pelvic floor muscle function, pelvic floor morphometry, urinary symptoms, quality of life, sexual function, and physical activity levels… Read more about this study
- Who is it for?
- Ages 18 to 65 years, women only
- Conditions the study is for
- Stress Urinary Incontinence (SUI), Dynamic Neuromuscular Stabilization, Pelvic Floor Muscle Training
- What is being tested?
- Dynamic Neuromuscular Stabilization Training and Pelvic Floor Muscle Training
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 51 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 16 Jul 2025to 30 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Female participants aged between 18 and 65 years
- Diagnosed with stress urinary incontinence or stress-dominant mixed urinary incontinence by a specialist physician
- Having the ability to voluntarily contract the pelvic floor muscles
- Literate in Turkish
- Willing and voluntarily consenting to participate in the study
Who cannot join
- Pregnancy
- Presence of urgency-predominant urinary incontinence symptoms or fecal incontinence
- Inability to understand or cooperate with assessment procedures
- Presence of any neurological or rheumatological disease
- Severe cardiac or pulmonary disease
- Uncontrolled diabetes mellitus or hypertension
Show all 15Show fewer
- Chronic liver and/or kidney failure
- Advanced pelvic organ prolapse (greater than grade 2)
- History of abdominal or pelvic surgery (including cesarean section) within the past year
- History of spinal surgery
- Current urinary tract infection
- History of pelvic radiation therapy
- Presence of spinal deformity
- History of acute low back pain within the past 4-6 weeks
- Receiving pelvic floor muscle training within the past three months
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Ege University, Faculty of Medicine, Department of Obstetrics & Gynecology
Izmir
Ayse Kardelen ACAR, MSc, acar.kardelen@gmail.com
Ayse Kardelen ACAR, MSc
About this study
Official title: Comparison of Effects of Dynamic Neuromuscular Stabilization Training and Pelvic Floor Muscle Training in Women With Stress Urinary Incontinence: A Randomized Controlled Trial
This randomized controlled trial aims to compare the pre- and post-treatment effects of Dynamic Neuromuscular Stabilization (DNS) training and Pelvic Floor Muscle Training (PFMT) on pelvic floor muscle function, pelvic floor morphometry, urinary symptoms, quality of life, sexual function, and physical activity levels in women with stress urinary incontinence (SUI).
Participants diagnosed with SUI by a specialist physician will be randomly assigned to one of three groups: DNS, PFMT, or a control group. Both DNS and PFMT interventions will be delivered as 12-week home exercise programs, performed five days a week and at least three times per day. To support adherence, participants will use an exercise diary. In addition, participants in the DNS and PFMT groups will attend the clinic twice a week for supervised sessions led by a physiotherapist.
The control group will receive a brochure containing lifestyle and bladder health recommendations but will not engage in any structured exercise program.
Read the detailed description
Stress urinary incontinence (SUI) is defined by the International Continence Society as involuntary urine leakage due to insufficient urethral closure pressure during episodes of increased intra-abdominal pressure (IAP), such as coughing, sneezing, laughing, or physical activity. The continence mechanism involves intrinsic urethral closure, structural support of the urethra, and lumbopelvic stability. These components are interconnected through the endopelvic fascia and neural pathways.
The core musculature-including the diaphragm, transversus abdominis (TrA), pelvic floor muscles, and lumbar multifidus-functions synergistically within the myofascial system to regulate IAP. This coordination is essential for maintaining the optimal function of genitourinary organs, especially the bladder.
Dynamic Neuromuscular Stabilization (DNS) targets this integrated spinal stabilization system. DNS exercises are based on developmental kinesiology principles, comparing adult stabilization patterns to those of healthy infants. The goal is to retrain the neuromuscular system through repetitive, functional movements to restore automatic IAP regulation and trunk stability.
Although DNS has demonstrated clinical effectiveness in managing musculoskeletal disorders, cerebral palsy, hemiplegia, and athletic injuries, its role in the management of SUI remains underexplored. By promoting synchronous activation of the deep stabilizers-including the diaphragm, TrA, multifidus, and pelvic floor-DNS may offer a more comprehensive therapeutic approach than isolated pelvic floor muscle training.
In this context, the main questions of this study it aims to answer are:
Does Dynamic Neuromuscular Stabilization (DNS) training have an effect on pelvic floor muscle function, pelvic floor morphometry, symptoms, quality of life, sexual function, and physical activity levels in women with stress urinary incontinence (SUI)? Does Pelvic Floor Muscle Training (PFMT) improve pelvic floor muscle function, pelvic floor morphometry, symptoms, quality of life, sexual function, and physical activity levels in women with stress urinary incontinence (SUI)? Is there a difference between DNS exercises and PFMT in terms of their effects on pelvic floor muscle function, pelvic floor morphometry, symptoms, quality of life, sexual function, and physical activity levels before and after treatment in women with SUI?
- Conditions
- Stress Urinary Incontinence (SUI), Dynamic Neuromuscular Stabilization, Pelvic Floor Muscle Training, Muscle Morphology, Urinary Symptoms, Quality of Life
- Being tested
- Dynamic Neuromuscular Stabilization Training, Pelvic Floor Muscle Training
- Keywords
- stress urinary incontinence, dynamic neuromuscular stabilization, pelvic floor muscle training, physical activity, quality of life, muscle morphology
- Medical subject headings
- Urinary Incontinence, Stress, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Dynamic Neuromuscular Stabilization TrainingOther
According to the principles of Dynamic Neuromuscular Stabilization (DNS), proper activation of the integrated spinal stabilization system requires that the abdominal muscles expand not only in the caudal direction but also posteriorly and laterally.Therefore, firstly, the physiotherapist will assess the expansion of the entire abdominal wall and teach the patient to regulate intra-abdominal pressure through correct breathing techniques. During training and exercises, a belt will be used. Participants will be instructed to maintain abdominal expansion toward the belt during exercises performed in positions supported by proper alignment. A four-phase exercise protocol based on developmental kinesiology principles will be implemented for the DNS group, beginning with supine-position exercises appropriate for the 3-month developmental stage.
They will be instructed to repeat the exercises at least three times per day.Patients will record their home exercise program using an exercise diary.
Pelvic Floor Muscle TrainingOther
Participants in the PFMT group will undergo a structured pelvic floor muscle training program supervised by a physiotherapist. The training will include verbal and manual instructions to ensure correct identification and isolated activation of the pelvic floor muscles without compensatory movements from the gluteal, abdominal, or thigh muscles using a NeuroTrac Simplex EMG-Biofeedback device.
The exercise protocol will consist of both slow and fast contractions, focusing on endurance, strength, and coordination.
The exercises will be performed in various positions (e.g., supine, sitting, standing) and will gradually progress in intensity and complexity over time, following the principles of motor learning stages. They will be instructed to repeat the exercises at least three times per day. Patients will record their home exercise program using an exercise diary.
| Study group | Role | What they receive |
|---|---|---|
| DNS group | Experimental | Women aged 18-65 who have stress or stress-dominant mixed urinary incontinence. They are followed up for 12 weeks, consisting of 2 days/week face-to-face training sessions with the physiotherapist and 5 days/week sessions conducted by themselves. Receives: Other: Dynamic Neuromuscular Stabilization Training |
| PFMT group | Active comparator | Women aged 18-65 who have stress or stress-dominant mixed urinary incontinence. They are followed up for 12 weeks, consisting of 2 days/week face-to-face training sessions with the physiotherapist and 5 days/week sessions conducted by themselves. Receives: Other: Pelvic Floor Muscle Training |
| Control | No intervention | Receiving patient education only and no exercise was applied to the subjects included in the control group. |
What is being measured
The primary outcome is the main question the study is designed to answer.
1-Hour Pad test
The 1-hour pad test is a standardized objective measurement of urinary leakage under controlled physical activity conditions (e.g., walking, coughing, stair climbing). Participants wear a pre-weighed pad during the test; an increase in weight reflects urine loss. It is used to quantify the severity of stress urinary incontinence (SUI).
Assessment Method: Pad weight difference in grams
Measured: Baseline and 12th week (at the end of the exercise program)
Pelvic Floor Morphometry
3D transperineal ultrasonography allows objective morphometric and functional assessment of all compartments of the pelvic floor. 3D images are taken during rest, maximal voluntary contraction, and Valsalva maneuver, and measurements are recorded for levator ani muscle thickness, levator ani diameter, hiatal area, and the distance between the levator ani, urethra, and symphysis pubis. These measurements will be performed by a urogynecologist.
Measured: Baseline and 12th week (at the end of the exercise program)
Pelvic Floor Muscle Strength and Endurance
The NeuroTract Simplex EMG-Biofeedback device will be used to assess pelvic floor muscle contraction strength (maximum squeeze pressure in cmH₂O or mmHg) and endurance (duration of sustained contraction). This provides an objective measure of muscle performance and training effect.
Measured: Baseline and 12th week (at the end of the exercise program)
Incontinence Quality of Life Questionnaire (I-QOL)
The Incontinence Quality of Life Questionnaire (I-QOL) is a validated self-administered instrument that assesses the impact of urinary incontinence on quality of life a 22 items, including social embarrassment, avoidance behaviors, and psychosocial effects. Higher scores indicate a better perceived quality of life.
A 2.5-point change in the I-QOL scale was determined to be the minimum clinically important difference (MCID) for women with urinary incontinence, representing a threshold at which patients typically report a noticeable improvement in quality of life. A 6.3-point improvement was predicted for the pre- and post-treatment assessment of the same group of women.
Measured: Baseline and 12th week (at the end of the exercise program)
Incontinence Episodes and Number of Pads Used (from 3-Day Bladder Diary)
The number of incontinence episodes and the number of pads used are recorded by participants over three consecutive days. This provides a semi-objective reflection of symptom frequency and the daily impact of SUI.
Assessment Tool: 3-Day Bladder Diary
Measured: Baseline and 12th week (at the end of the exercise program)
Secondary outcomes (5)
24-h Pad Test
A longer-duration objective measurement of urinary leakage. Participants wear a pre-weighed pad for 24 hours during typical daily activities. The post-use weight quantifies real-life incontinence severity.
Assessment Method: Pad weight difference in grams
Measured: Baseline and 12th week (at the end of the exercise program)
Frequency, Nocturia, and Fluid Intake
Additional parameters recorded in the bladder diary include daily voiding frequency, number of nocturnal voids (nocturia), and total fluid intake. These measures reflect bladder behavior and potential treatment-related improvements.
Assessment Tool: 3-Day Bladder Diary
Measured: Baseline and 12th week (at the end of the exercise program)
Pelvic Floor Muscle Strength (Digital Vaginal Palpation - Oxford Scale)
A trained physiotherapist will assess voluntary pelvic floor contractions using the Modified Oxford Scale (0= no contraction; 1= very weak; 2= weak; 3= moderate (with lifting); 4= good (with lifting); 5= strong (with lifting)). This semi-subjective but clinically accepted method provides a rapid evaluation of muscle activation ability.
Assessment Method: Vaginal digital palpation
Measured: Baseline and 12th week (at the end of the exercise program)
Female Sexual Function Index (FSFI)
A 19-item questionnaire evaluating six domains of female sexual function: desire, arousal, lubrication, orgasm, satisfaction, and pain. It is widely used in pelvic floor research and helps assess the broader quality-of-life effects of interventions.
Scoring Range: 2-36 (higher scores = better function)
Measured: Baseline and 12th week (at the end of the exercise program)
Physical Activity Levels
A validated questionnaire that quantifies physical activity levels across walking, moderate, and vigorous activities. Results are expressed in MET-minutes per week and allow for analysis of whether interventions affect physical activity engagement. The questionnaire consists of four separate sections and seven questions. It includes questions about the frequency of walking, moderate, and vigorous activities in the past week, and the time spent in these activities. The final question asks about the time spent sitting daily. Higher scores indicate a better outcome. According to the IPAQ scoring protocol, participants are classified into three categories based on total MET-minutes/week: Inactive (<600 MET-minutes/week ), Minimally Active (600-3000 MET-minutes/week ), and Health-Enhancing Physically Active (≥ 3000 MET-minutes/week) Assessment Tool: International Physical Activity Questionnaire - Short Form (IPAQ-SF)
Measured: Baseline and 12th week (at the end of the exercise program)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jul 2025
- Study start16 Jul 2025
- Primary completion30 Aug 2026 (estimated)
- Study completion30 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Stress Urinary Incontinence (SUI)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 51 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Izmir Katip Celebi University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sevtap Günay, Izmir Katip Celebi University
- Investigators
- Ayse Kardelen ACAR, MSc, Principal investigator, Izmir Katıp Celebi University, Institute of Health SciencesSevtap GUNAY UCURUM, Professor, Study director, Izmir Katıp Celebi University, Faculty of Health Sciences, Department of Physiotherapy and RehabilitationAhmet Ozgur YENIEL, Professor, Study chair, Ege University, Faculty of Medicine, Department of Obstetrics & Gynecology
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07075900
- Sponsor's protocol ID
- DYNAPELVIS-SUI2025
- Acronym
- DYNA-SUI
- Status last verified
- Jul 2025
- First submitted
- 10 Jul 2025
- Last updated
- 25 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Effects of Dynamic Neuromuscular Stabilization Training and Pelvic Floor Muscle Training in Women With Stress Urinary Incontinence: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07075900
- Acronym / sponsor ID
- DYNA-SUI / DYNAPELVIS-SUI2025
- Conditions
- Stress Urinary Incontinence (SUI), Dynamic Neuromuscular Stabilization, Pelvic Floor Muscle Training, Muscle Morphology, Urinary Symptoms, Quality of Life
- Keywords
- stress urinary incontinence, dynamic neuromuscular stabilization, pelvic floor muscle training, physical activity, quality of life, muscle morphology
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 51 participants (estimated)
- Lead sponsor
- Izmir Katip Celebi UniversityUniversity, hospital or other
- Study start
- 16 Jul 2025 (actual)
- Primary completion
- 30 Aug 2026 (estimated)
- Study completion
- 30 Dec 2026 (estimated)
- First posted
- 20 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled trial aims to compare the pre- and post-treatment effects of Dynamic Neuromuscular Stabilization (DNS) training and Pelvic Floor Muscle Training (PFMT) on pelvic floor muscle function, pelvic floor morphometry, urinary symptoms, quality of life, sexual function, and physical activity levels in women with stress urinary incontinence (SUI).
Participants diagnosed with SUI by a specialist physician will be randomly assigned to one of three groups: DNS, PFMT, or a control group. Both DNS and PFMT interventions will be delivered as 12-week home exercise programs, performed five days a week and at least three times per day. To support adherence, participants will use an exercise diary. In addition, participants in the DNS and PFMT groups will attend the clinic twice a week for supervised sessions led by a physiotherapist.
The control group will receive a brochure containing lifestyle and bladder health recommendations but will not engage in any structured exercise program.
Detailed description
Stress urinary incontinence (SUI) is defined by the International Continence Society as involuntary urine leakage due to insufficient urethral closure pressure during episodes of increased intra-abdominal pressure (IAP), such as coughing, sneezing, laughing, or physical activity. The continence mechanism involves intrinsic urethral closure, structural support of the urethra, and lumbopelvic stability. These components are interconnected through the endopelvic fascia and neural pathways.
The core musculature-including the diaphragm, transversus abdominis (TrA), pelvic floor muscles, and lumbar multifidus-functions synergistically within the myofascial system to regulate IAP. This coordination is essential for maintaining the optimal function of genitourinary organs, especially the bladder.
Dynamic Neuromuscular Stabilization (DNS) targets this integrated spinal stabilization system. DNS exercises are based on developmental kinesiology principles, comparing adult stabilization patterns to those of healthy infants. The goal is to retrain the neuromuscular system through repetitive, functional movements to restore automatic IAP regulation and trunk stability.
Although DNS has demonstrated clinical effectiveness in managing musculoskeletal disorders, cerebral palsy, hemiplegia, and athletic injuries, its role in the management of SUI remains underexplored. By promoting synchronous activation of the deep stabilizers-including the diaphragm, TrA, multifidus, and pelvic floor-DNS may offer a more comprehensive therapeutic approach than isolated pelvic floor muscle training.
In this context, the main questions of this study it aims to answer are:
Does Dynamic Neuromuscular Stabilization (DNS) training have an effect on pelvic floor muscle function, pelvic floor morphometry, symptoms, quality of life, sexual function, and physical activity levels in women with stress urinary incontinence (SUI)? Does Pelvic Floor Muscle Training (PFMT) improve pelvic floor muscle function, pelvic floor morphometry, symptoms, quality of life, sexual function, and physical activity levels in women with stress urinary incontinence (SUI)? Is there a difference between DNS exercises and PFMT in terms of their effects on pelvic floor muscle function, pelvic floor morphometry, symptoms, quality of life, sexual function, and physical activity levels before and after treatment in women with SUI?
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| DNS group | Experimental | Other: Dynamic Neuromuscular Stabilization TrainingWomen aged 18-65 who have stress or stress-dominant mixed urinary incontinence. They are followed up for 12 weeks, consisting of 2 days/week face-to-face training sessions with the physiotherapist and 5 days/week sessions conducted by themselves. |
| PFMT group | Active comparator | Other: Pelvic Floor Muscle TrainingWomen aged 18-65 who have stress or stress-dominant mixed urinary incontinence. They are followed up for 12 weeks, consisting of 2 days/week face-to-face training sessions with the physiotherapist and 5 days/week sessions conducted by themselves. |
| Control | No intervention | –Receiving patient education only and no exercise was applied to the subjects included in the control group. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Female participants aged between 18 and 65 years
- Diagnosed with stress urinary incontinence or stress-dominant mixed urinary incontinence by a specialist physician
- Having the ability to voluntarily contract the pelvic floor muscles
- Literate in Turkish
- Willing and voluntarily consenting to participate in the study
Key exclusion criteria (15 listed)
- Pregnancy
- Presence of urgency-predominant urinary incontinence symptoms or fecal incontinence
- Inability to understand or cooperate with assessment procedures
- Presence of any neurological or rheumatological disease
- Severe cardiac or pulmonary disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Dynamic Neuromuscular Stabilization TrainingAccording to the principles of Dynamic Neuromuscular Stabilization (DNS), proper activation of the integrated spinal stabilization system requires that the abdominal muscles expand not only in the caudal direction but also posteriorly and laterally.Therefore, firstly, the physiotherapist will assess the expansion of the entire abdominal wall and teach the patient to regulate intra-abdominal pressure through correct breathing techniques. During training and exercises, a belt will be used. Participants will be instructed to maintain abdominal expansion toward the belt during exercises performed in positions supported by proper alignment. A four-phase exercise protocol based on developmental kinesiology principles will be implemented for the DNS group, beginning with supine-position exercises appropriate for the 3-month developmental stage. They will be instructed to repeat the exercises at least three times per day.Patients will record their home exercise program using an exercise diary. | Other | DNS group |
| Pelvic Floor Muscle TrainingParticipants in the PFMT group will undergo a structured pelvic floor muscle training program supervised by a physiotherapist. The training will include verbal and manual instructions to ensure correct identification and isolated activation of the pelvic floor muscles without compensatory movements from the gluteal, abdominal, or thigh muscles using a NeuroTrac Simplex EMG-Biofeedback device. The exercise protocol will consist of both slow and fast contractions, focusing on endurance, strength, and coordination. The exercises will be performed in various positions (e.g., supine, sitting, standing) and will gradually progress in intensity and complexity over time, following the principles of motor learning stages. They will be instructed to repeat the exercises at least three times per day. Patients will record their home exercise program using an exercise diary. | Other | PFMT group |
Primary outcome
1-Hour Pad test
Time frame: Baseline and 12th week (at the end of the exercise program)
The 1-hour pad test is a standardized objective measurement of urinary leakage under controlled physical activity conditions (e.g., walking, coughing, stair climbing). Participants wear a pre-weighed pad during the test; an increase in weight reflects urine loss. It is used to quantify the severity of stress urinary incontinence (SUI). Assessment Method: Pad weight difference in grams
Pelvic Floor Morphometry
Time frame: Baseline and 12th week (at the end of the exercise program)
3D transperineal ultrasonography allows objective morphometric and functional assessment of all compartments of the pelvic floor. 3D images are taken during rest, maximal voluntary contraction, and Valsalva maneuver, and measurements are recorded for levator ani muscle thickness, levator ani diameter, hiatal area, and the distance between the levator ani, urethra, and symphysis pubis. These measurements will be performed by a urogynecologist.
Pelvic Floor Muscle Strength and Endurance
Time frame: Baseline and 12th week (at the end of the exercise program)
The NeuroTract Simplex EMG-Biofeedback device will be used to assess pelvic floor muscle contraction strength (maximum squeeze pressure in cmH₂O or mmHg) and endurance (duration of sustained contraction). This provides an objective measure of muscle performance and training effect.
Incontinence Quality of Life Questionnaire (I-QOL)
Time frame: Baseline and 12th week (at the end of the exercise program)
The Incontinence Quality of Life Questionnaire (I-QOL) is a validated self-administered instrument that assesses the impact of urinary incontinence on quality of life a 22 items, including social embarrassment, avoidance behaviors, and psychosocial effects. Higher scores indicate a better perceived quality of life. A 2.5-point change in the I-QOL scale was determined to be the minimum clinically important difference (MCID) for women with urinary incontinence, representing a threshold at which patients typically report a noticeable improvement in quality of life. A 6.3-point improvement was predicted for the pre- and post-treatment assessment of the same group of women.
Incontinence Episodes and Number of Pads Used (from 3-Day Bladder Diary)
Time frame: Baseline and 12th week (at the end of the exercise program)
The number of incontinence episodes and the number of pads used are recorded by participants over three consecutive days. This provides a semi-objective reflection of symptom frequency and the daily impact of SUI. Assessment Tool: 3-Day Bladder Diary
5 secondary outcomes
24-h Pad Test
Time frame: Baseline and 12th week (at the end of the exercise program)
Frequency, Nocturia, and Fluid Intake
Time frame: Baseline and 12th week (at the end of the exercise program)
Pelvic Floor Muscle Strength (Digital Vaginal Palpation - Oxford Scale)
Time frame: Baseline and 12th week (at the end of the exercise program)
Female Sexual Function Index (FSFI)
Time frame: Baseline and 12th week (at the end of the exercise program)
Physical Activity Levels
Time frame: Baseline and 12th week (at the end of the exercise program)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Mar 2026.
- Individual participant dataSharing planned: No
Related trials for Stress Urinary Incontinence (SUI)
Not yet recruiting
Anterior Bridge-Preserving Versus Conventional Early Apical Release in Bipolar Enucleation of the Prostate
Benign Prostatic Hyperplasia, Benign Prostatic Obstruction
Active, not recruiting
A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)
Stress Urinary Incontinence (SUI)
Recruiting
Comparing the Effect of Two Types of Pelvic Floor Muscle Stimulation Devices to Improve Symptoms of Urinary Incontinence in Women.
Urinary Incontinence, Mixed Urinary Incontinence
Recruiting
Effect of High-Intensity Focused Electromagnetic (HIFEM) Technology in the Treatment of SUI in Chinese Men Undergone Robotic Radical Prostatectomy
Urinary Incontinence , Stress, Prostatectomy
Recruiting
The Effects of Expiratory Muscle Strength Training in Women With Stress Urinary Incontinence
Stress Urinary Incontinence (SUI)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ayse Kardelen ACAR, MSc principal investigator
Izmir Katıp Celebi University, Institute of Health Sciences
Sevtap GUNAY UCURUM, Professor study director
Izmir Katıp Celebi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
Ahmet Ozgur YENIEL, Professor study chair
Ege University, Faculty of Medicine, Department of Obstetrics & Gynecology
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Dynamic Neuromuscular Stabilization Training and Pelvic Floor Muscle Training in people with Stress Urinary Incontinence (SUI) and Dynamic Neuromuscular Stabilization, run by Izmir Katip Celebi University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 25 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Sevtap GUNAY UCURUM, Professor (+90 232 3293535/4717, sevtapgunay.tfd@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
1-Hour Pad test (time frame: Baseline and 12th week (at the end of the exercise program)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Mar 2026.